D.A. DAVIDSON & CO. - REDHILL BIOPHARMA LTD ownership

REDHILL BIOPHARMA LTD's ticker is RDHL and the CUSIP is 757468103. A total of 31 filers reported holding REDHILL BIOPHARMA LTD in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
D.A. DAVIDSON & CO. ownership history of REDHILL BIOPHARMA LTD
ValueSharesWeighting
Q4 2022$1,473
-70.5%
10,5000.0%0.00%
Q3 2022$5,000
-61.5%
10,500
-27.6%
0.00%
Q2 2022$13,000
-69.0%
14,500
-13.7%
0.00%
Q1 2022$42,000
-2.3%
16,8000.0%0.00%
Q4 2021$43,000
-44.2%
16,8000.0%0.00%
-100.0%
Q3 2021$77,000
-62.4%
16,800
-43.6%
0.00%
-50.0%
Q2 2021$205,000
-6.0%
29,8000.0%0.00%
-33.3%
Q1 2021$218,000
-9.5%
29,8000.0%0.00%
-25.0%
Q4 2020$241,000
+22.3%
29,800
+54.4%
0.00%
+33.3%
Q3 2020$197,000
+77.5%
19,300
+17.0%
0.00%
+50.0%
Q2 2020$111,000
+122.0%
16,500
+50.0%
0.00%
+100.0%
Q1 2020$50,000
-71.3%
11,000
-55.6%
0.00%
-66.7%
Q3 2019$174,000
+4.2%
24,750
-3.9%
0.00%0.0%
Q2 2019$167,000
-35.3%
25,750
-16.9%
0.00%
-25.0%
Q1 2019$258,000
+50.0%
31,0000.0%0.00%
+33.3%
Q4 2018$172,000
-41.9%
31,000
-7.5%
0.00%
-40.0%
Q3 2018$296,000
+3.5%
33,5000.0%0.01%
-16.7%
Q2 2018$286,000
+76.5%
33,500
+6.3%
0.01%
+100.0%
Q1 2018$162,000
-19.0%
31,500
-19.2%
0.00%
-25.0%
Q4 2017$200,000
-57.9%
39,000
-11.4%
0.00%
-55.6%
Q3 2017$475,000
+25.3%
44,0000.0%0.01%0.0%
Q2 2017$379,000
-1.0%
44,000
+10.0%
0.01%0.0%
Q1 2017$383,000
-1.0%
40,000
+8.1%
0.01%0.0%
Q4 2016$387,000
+5.2%
37,000
+39.6%
0.01%0.0%
Q3 2016$368,00026,5000.01%
Other shareholders
REDHILL BIOPHARMA LTD shareholders Q2 2018
NameSharesValueWeighting ↓
Ibex Investors LLC 1,892,593$15,292,0006.10%
GAGNON SECURITIES LLC 281,080$2,271,0000.36%
DISCIPLINED GROWTH INVESTORS INC /MN 2,029,195$16,396,0000.32%
Annandale Capital, LLC 43,532$352,0000.29%
WOODWARD DIVERSIFIED CAPITAL, LLC 23,000$186,0000.12%
IRONWOOD INVESTMENT MANAGEMENT LLC 20,328$164,0000.10%
Claret Asset Management Corp 54,972$444,0000.09%
Migdal Insurance & Financial Holdings Ltd. 890,339$7,194,0000.08%
Shay Capital LLC 47,800$386,0000.08%
ARS Investment Partners, LLC 77,714$628,0000.08%
View complete list of REDHILL BIOPHARMA LTD shareholders